Mirae Asset Global ETFs Holdings’s Esperion Therapeutics ESPR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Buy	116,595 +4,126	+4%	+$11.5K	﹤0.01%	2166
2026 Q1	$308K	Buy	112,469 +3,842	+4%	+$12.2K	﹤0.01%	2131
2025 Q4	$402K	Buy	108,627 +14,854	+16%	+$48K	﹤0.01%	1991
2025 Q3	$248K	Sell	93,773 -13,774	-13%	-$26.6K	﹤0.01%	2212
2025 Q2	$106K	Sell	107,547 -4,802	-4%	-$4.81K	﹤0.01%	2588
2025 Q1	$162K	Buy	112,349 +4,815	+4%	+$8.87K	﹤0.01%	2420
2024 Q4	$237K	Buy	107,534 +3,279	+3%	+$7.65K	﹤0.01%	2302
2024 Q3	$172K	Buy	+104,255	New	+$211K	﹤0.01%	2436

Other funds holding ESPR

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ESPR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Esperion Therapeutics (ESPR) stake by 3.7% in Q2 2026, buying an estimated $11.5K and bringing the position to 116,595 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Mirae Asset Global ETFs Holdings first reported a position in ESPR in Q3 2024 and has held it in 8 quarters since. The position peaked at $402K in Q4 2025. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

Mirae Asset Global ETFs Holdings held 116,595 shares of Esperion Therapeutics worth $368K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 4,126 Esperion Therapeutics shares in Q2 2026, an estimated $11.5K.
Esperion Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2166 holding.
Mirae Asset Global ETFs Holdings first reported a position in Esperion Therapeutics in Q3 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Esperion Therapeutics position peaked at $402K in Q4 2025.
191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.